Novel drug delivery magnetite nano-systems used in antimicrobial therapy

Current Organic Chemistry

Volumn 18, Issue 2, 2014, Pages 185-191

  Holban, Alina Maria ^a   Grumezescu, Alexandru Mihai ^b   Gestal, Monica Cartelle ^c   Mogoantǎ, Laurenţiu ^d   Mogoşanu, George Dan ^d  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Antimicrobial therapy; Drug delivery; Drug targeting; Magnetite nanoparticles; Nonpolar magnetite; Polar magnetite

Indexed keywords

CONTROLLED DRUG DELIVERY; MAGNETITE NANOPARTICLES; MEDICAL APPLICATIONS; MICROORGANISMS; NANOMAGNETICS; NANOSYSTEMS; TARGETED DRUG DELIVERY;

ANTI-MICROBIAL PROPERTIES; ANTIBIOFILMS; ANTIMICROBIAL THERAPY; BIOMEDICAL APPLICATIONS; DRUG-DELIVERY SYSTEMS; DRUG-TARGETING; NANO-SYSTEMS; NON-POLAR; NONPOLAR MAGNETITE; POLAR MAGNETITE;

MAGNETITE;

EID: 84894072635     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/13852728113176660142     Document Type: Article

References (80)

1. Antimicrobial resistance. World Health organization. May 2013, http://www.who.int/mediacentre/factsheets/fs194/en/
2. Davies, J.; Davies, D. Origins and Evolution of Antibiotic Resistance. Microbiol. Mol. Biol. Rev., 2010, 417-433.
3. Todar, K. Textbook of Bacteriology-Bacterial Resistance to Antibiotics. 2008-2012, Todar's Online Textbook of Bacteriology, http://www.textbookofbacteriology.net
4. Grumezescu, A.M.; Andronescu, E.; Ficai, A.; Ficai, D.; Huang, K.S.; Gheorghe, I.; Chifiriuc, M.C. Water Soluble magnetic biocomposite with potential applications for the antimicrobial therapy. Biointerface Res. Appl. Chem., 2012, 2, 469-475.
5. Cotar, A.I.; Grumezescu, A.M.; Huang, K.S.; Chifiriuc, C.M.; Radulescu, R. Magnetite nanoparticles influence the efficacy of antibiotics against biofilm embedded Staphylococcus aureus cells. Biointerface Res. Appl. Chem. 2013, 3, 559-565
6. Grumezescu, A.M.; Ficai, A.; Ficai, D.; Prdean, G.; Chifiriuc, M.C. Polymeric magnetic silica microspheres as a drug loader for antimicrobial delivery substances. Digest J. Nanomat. Biosctruct., 2012, 7, 1891-1896
7. Morar, M.; Wright, G.D. The Genomic Enzymology of Antibiotic Resistance. Annu. Rev. Genet., 2010, 44, 25-51.
8. Liu, B.; Pop, M. ARDB-Antibiotic Resistance Genes Database. Nucleic Acids Res., 2009, 37, D443-D447.
9. Lazar, V. Quorum sensing in biofilms e How to destroy the bacterial citadels or their cohesion/power?, Anaerobe., 2011, 17, 280-285.
10. Saviuc, C.; Grumezescu, A.M.; Chifiriuc, M.C.; Bleotu, C.; Stanciu, G.; Hristu, R.; Mihaiescu, D.; Lazar, V. In vitro methods for the study of microbial biofilms. Biointerface Res. Appl. Chem., 2011, 1,31.
11. Anghel, I.; Holban, A.M.; Andronescu, E.; Grumezescu, A.M.; Chifiriuc, M.C. Efficient surface functionalization of wound dressings by a phytoactive nanocoating refractory to Candida albicans biofilm development. Biointerphases., 2013, 8, 12. (25 April 2013)
12. Høiby, N.; Bjarnsholt, T.; Givskov, M.; Molin, S.; Ciofu, O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents., 2010, 4, 322-32.
13. McGowan, J.E. Economic Impact of Antimicrobial Resistance. Emerg. Infect. Dis. 2001, 7, 286-292.
14. Nikolaou, K.C.; Montagnon, T. Molecules that changed the world. Wiley VCH, Weinheim, Germany, 2008.
15. Liu, L.; Xu, K.; Wang, H.; Tan, P.K.J.; Fan, W.; Venkatraman, S.S.; Li, L.; Yang, Y.Y. Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent. Nature Nanotechnol., 2009, 4, 457-463.
16. Bradbury, J. My enemy's enemy is my friend. The Lancet, 2004, 363, 624-625.
17. Peters, B.M.; Shirtliff, M.E.; Jabra-Rizk, M.A. Antimicrobial Peptides: Primeval Molecules or Future Drugs?. PLoS Pathog., 2010, 6, e1001067.
18. 12 nanostructures and 2-(4-ethylphenoxy) methyl)-N-(substituted-phenylcarbamothioyl)-benzamides. Nanoscale Res. Lett., 2012, 7, 513.
19. Jiang, Y.N.; Mo, H.Y.; Yu, D.G. Electrospun drug-loaded core-sheath PVP/zein nanofibers for biphasic drug release. Int. J. Pharm., 2012, 438, 232-239.
20. Huang, L.Y.; Branford-White, C.; Shen, X.X.; Yu, D.G.; Zhu, L.M. Timeengineeringed biphasic drug release by electrospun nanofiber meshes. Int. J. Pharm., 2012, 436, 88-96.
21. 12 core/shell nanosystem. Lett. Appl. NanoBioSci., 2012, 1,31-35.
22. Wang, Y.J.; Wang, C.; Gong, C.Y.; Wang, Y.J.; Guo, G.; Luo, F.; Qian, Z.Y. Polysorbate 80 coated poly (ε-caprolactone)-poly (ethylene glycol)-poly (ε-caprolactone) micelles for paclitaxel delivery. Int. J. Pharm., 2012, 434, 1-8.
23. 4/Cephalosporins Hybrid Materials For Targeted Drug Delivery. Rom. J. Mater., 2011, 41,383-387.
24. Tripathy, S.; Das, S.; Chakraborty, S.P.; Sahu, S.K.; Pramanik, P.; Roy, S. Synthesis, characterization of chitosan-tripolyphosphate conjugated chloroquine nanoparticle and its in vivo anti-malarial efficacy against rodent parasite: A dose and duration dependent approach. Int. J. Pharm., 2012, 434, 292-305.
25. Eidi, H.; Joubert, O.; Némos, C.; Grandemange, S.; Mograbi, B.; Foliguet, B.; Tournebize, J.; Maincent, P.; Le Faou, A.; Aboukhamis, I.; Rihn, B.H. Drug delivery by polymeric nanoparticles induces autophagy in macrophages. Int. J. Pharm., 2012, 422, 495-503.
26. Andronescu, E.; Grumezescu, A.M.; Ficai, A.; Gheorghe, I.; Chifiriuc, M.; Mihaiescu, D.E.; Lazar, V. In vitro efficacy of antibiotic magnetic dextran microspheres complexes agains Staphylococcus aures and Pseudomonas aeruginosa strains. Biointerface Res. Appl. Chem., 2012, 2,332-338.
27. Nanotechnology In Medicine: Huge Potential, But What Are The Risks? Medical news today, 2012. http://www.medicalnewstoday.com/ articles/ 244972.php
28. Reul, R.; Nguyen, J.; Biela, A.; Marxer, E.; Bakowsky, U.; Klebe, G.; Kissel, T. Biophysical and biological investigation of DNA nano-complexes with a non-toxic, biodegradable amine-modified hyperbranched polyester. Int. J. Pharm., 2012, 436, 97-105.
29. Endres, T.; Zheng, M.; Beck-Broichsitter, M.; Kissel, T. Lyophilised readyto-use formulations of PEG-PCL-PEI nano-carriers for siRNA delivery. Int. J. Pharm., 2012, 428, 121-124.
30. Wang, T.; Upponi, J.R.; Torchilin, V.P. Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies. Int. J. Pharm., 2012, 427, 3-20.
31. Tang, S.Y.; Sivakumar, M.; Min-Hwei Ng, A.; Shridharan, P. Antiinflammatory and analgesic activity of novel oral aspirin-loaded nanoemulsion and nano multiple emulsion formulations generated using ultrasound cavitation. Int. J. Pharm., 2012, 430, 299-306.
32. Zhang, L.; Pornpattananangkul, D.; Hu, C.M.J.; Huang, C.M. Development of Nanoparticles for Antimicrobial Drug Delivery. Cur. Med. Chem., 2010, 17, 585-594.
33. Kontogiannopoulos, K.N.; Assimopoulou, A.N.; Hatziantoniou, S.; Karatasos, K.; Demetzos, C.; Papageorgiou, V.P. Chimeric advanced drug delivery nano systems (chi-aDDnSs) for shikonin combining dendritic and liposomal technology. Int. J. Pharm., 2012, 422,381-389.
34. Taylor, E.; Webster, T.J. Reducing infections through nanotechnology and nanoparticles. Int. J. Nanomed., 2011, 6, 1463-1473.
35. van Bracht, E.; Raavé, R.; Verdurmen, W.P.R.; Wismans, R.G.; Geutjes, P.J.; Brock, R.E.; Oosterwijk, E.; van Kuppevelt, T.H.; Daamen, W.F. Lyophilisomes as a new generation of drug delivery capsules. Int. J. Pharm., 2012, 439, 127-135.
36. Narvekar, M.; Xue, H.Y.; Wong, H.L. A novel hybrid delivery system: Polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA). Int. J. Pharm., 2012, 436, 721-731.
37. Kaasalainen, M.; Mäkilä, E.; Riikonen, J.; Kovalainen, M.; Järvinen, K.; Herzig, K.H.; Lehto, V.P.; Salonen, J. Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations. Int. J. Pharm., 2012, 431, 230-236.
38. Mihaiescu, D.E.; Grumezescu, A.M.; Balaure, P.C.; Mogosanu, D.E.; Traistaru, V. Magnetic scaffold for drug targeting: evaluation of cephalosporins controlled release profile. Biointerface Res. Appl. Chem., 2011, 1, 191-195.
39. Grumezescu, A.M.; Saviuc, C.; Holban, A.; Hristu, R.; Stanciu, G.; Chifiriuc, C.; Mihaiescu, D.; Balaure, P.; Lazar, V. Magnetic chitosan for drug targeting and in vitro drug delivery response. Biointerface Res. Appl. Chem., 2011, 1, 160.
40. Grumezescu, A.M.; Andronescu, E.; Ficai, A.; Bleotu, C.; Chifiriuc, M.C. Chitin based biomaterial for antimicrobial therapy: fabrication, characterization and in vitro profile based interaction with eukaryotic and prokaryotic cells. Biointerface Res. Appl. Chem., 2012, 2, 438-446.
41. Espuelas, M.S.; Legrand, P.; Loiseau, P.M.; Bories, C.; Barratt, G.; Irache, J.M. In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres. J. Drug. Target., 2002, 10, 593-9.
42. Skidan, I.N.; Gel'perina, S.E.; Severin, S.E.; Guliaev, A.E. Enhanced activity of rifampicin loaded with polybutyl cyanoacrylate nanoparticles in relation to intracellularly localized bacteria. Antibiot. Khimioter., 2003, 48, 23-6.
43. Forestier, F.; Gerrier, P.; Chaumard, C.; Quero, A. M.; Couvreur, P.; Labarre, C. Effect of nanoparticle-bound ampicillin on the survival of Listeria monocytogenes in mouse peritoneal macrophages. J. Antimicrob. Chemother., 1992,30, 173-9.
44. Gupta, A. K.; Cooper, E. A. Update in antifungal therapy of dermatophytosis. Mycopathologia., 2008, 166, 353-67.
45. Yang, W.; Wiederhold, N. P.; Williams, R. O., 3rd Drug delivery strategies for improved azole antifungal action. Expert. Opin. Drug Deliv., 2008, 5, 1199-216.
46. Sanna, V.; Gavini, E.; Cossu, M.; Rassu, G.; Giunchedi, P. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J. Pharm. Pharmacol., 2007, 59, 1057-64.
47. Sousa, C.; Botelho, C.; Oliveira, R. Nanotechnology applied to medical biofilms control. Science against microbial pathogens: communicating current research and technological advances, A. Méndez-Vilas (Ed.). Formatex., 2011, 878-888.
48. Hu, C.M.J.; Fang, R.H.; Copp, J.; Luk, B.T., Zhang, L. A biomimetic nanosponge that absorbs pore-forming toxins. Nature Nanotechnol., 2013, doi:10.1038/nnano.2013.54.
49. Vadlapudi, A.D.; Vadlapatla, R.K.; Kwatra, D.; Earla, R.; Samanta, S.K.; Pal, D.; Mitra, A.K. Targeted lipid based drug conjugates: A novel strategy for drug delivery. Int. J. Pharm., 2012, 434, 315-324.
50. Rollett, A.; Reiter, T.; Nogueira, P.; Cardinale, M.; Loureiro, A.; Gomes, A.; Cavaco-Paulo, A.; Moreira, A.; Carmo, A.M.; Guebitz, G.M. Folic acidfunctionalized human serum albumin nanocapsules for targeted drug delivery to chronically activated macrophages. Int. J. Pharm., 2012, 427, 460-466.
51. Lee, D.J.; Park, G.Y.; Oh, K.T.; Oh, N.M.; Kwag, D.S.; Youn, Y.S. Oh, Y.T.; Park, J.W.; Lee, E.S. Multifunctional poly (lactide-co-glycolide) nanoparticles for luminescence/magnetic resonance imaging and photodynamic therapy. Int. J. Pharm., 2012, 434, 257-263.
52. Kim, J.E.; Shin, J.Y.; Cho, M.H. Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. Arch. Toxicol., 2012, 86, 685-700.
53. Grumezescu, A.M.; Saviuc, C.; Holban, A.; Hristu, R.; Stanciu, G.; Chifiriuc, C.; Mihaiescu, D.; Balaure, P.; Lazar, V. Magnetic chitosan for drug targeting and in vitro drug delivery response. Biointerface Res. Appl. Chem., 2011, 1, 160.
54. Saviuc, C.; Grumezescu, A.M.; Holban, A.; Chifiriuc, C.; Mihaiescu, D.; Lazar, V. Hybrid nanostructurated material for biomedical applications. Biointerface Res. Appl. Chem. 2011, 1, 64.
55. Chifiriuc, C.; Grumezescu, V.; Grumezescu, A.M.; Saviuc, C.; Lazǎr, V.; Andronescu, E. Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Res. Lett., 2012, 7, 209.
56. Anghel, I.; Grumezescu, A.M.; Andronescu, E.; Anghel, A.G.; Ficai, A.; Saviuc, C.; Grumezescu, V.; Vasile, B.S., Chifiriuc, M.C. Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development. Nanoscale Res. Lett., 2012, 7, 501.
57. Anghel, I.; Holban, A.M.; Grumezescu, A.M.; Andronescu, E.; Ficai, A.; Anghel, A.G.; Maganu, M.; Lazǎr, V.; Chifiriuc, M.C. Modified wound dressing with phytonanostructured coating to prevent staphylococcal and pseudomonal biofilm development. Nanoscale Res. Lett., 2012, 7, 690.
58. 12 nanostructures and 2-(4-ethylphenoxy) methyl)-N-(substituted-phenylcarbamothioyl)-benzamides. Nanoscale Res. Lett., 2012, 7, 513.
59. Azhar, S.L.; Lotfipour, F. Magnetic nanoparticles for antimicrobial drug delivery. Pharmazie., 2012, 67, 817-21.
60. Niemirowicz, K.; Markiewicz, K.H.; Wilczewska, A.Z.; Car, H. Magnetic nanoparticles as new diagnostic tools in medicine. Adv. Med. Sci., 2012, 57, 196-207.
61. Hanna, A.; Berg, M.; Stout, V.; Razatos, A. Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli. Appl. Environ. Microbiol., 2003, 69, 4474-4481.
62. Schladt, T.D.; Schneider, K.; Schild, H.; Tremel, W. Synthesis and biofunctionalization of magnetic nanoparticles for medical diagnosis and treatment. Dalton T., 2011, 40, 6315-43.
63. Mihaiescu, D.E.; Horja, M.; Gheorghe, I.; Ficai, A.; Grumezescu, A.M.; Bleotu, C.; Chifiriuc, C.M. Water soluble magnetite nanoparticles for antimicrobial drugs delivery. Lett. Appl. Nanobiosci., 2012, 1, 45-49.
64. Timko, M.; Koneracka, M.; Tomasovicova, N.; Kopcansky, P.; Zavisova, V. Magnetite polymer nanospheres loaded by Indomethacin for antiinflammatory therapy. J. Magn. Magn. Mater., 2006, 300, 191-194.
65. Grumezescu, A.M.; Saviuc, C.; Holban, A.; Hristu, R.; Croitoru, C.; Stanciu, G.; Chifiriuc, C.; Mihaiescu, D.; Balaure, P.; Lazar, V. Magnetic chitosan for drug targeting and in vitro drug delivery response. Biointerface Res. Appl. Chem., 2011, 1, 160-165.
66. Avilés, M.O.; Ebner, A.D.; Ritter, J.A. Ferromagnetic seeding for the magnetic targeting of drugs and radiation in capillary beds. J. Magn. Magn. Mater., 2007, 310, 131-144.
67. Zhang, L.; Jiang, Y.; Ding, Y.; Povey, M.; York, D. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). J. Nanoparticle. Res., 2007, 9, 479-489.
68. Seil, J.T.; Webster, T.J. Antimicrobial applications of nanotechnology: methods and literature. Int. J. Nanomed., 2012, 7, 2767-2781.
69. Azam, A.; Ahmed, A.S.; Oves, M.; Khan, M.S.; Habib, S.S.; Memic, A. Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study. Int. J. Nanomed., 2012, 7, 6003-6009.
70. Cotar, A.I.; Grumezescu, A.M.; Andronescu, E.; Voicu, G.; Ficai, A.; Ou, K.L.; Huang, K.S.; Chifiriuc, M.C. Nanotechnological solution for improving the antibiotic efficiency against biofilms developed by Gram-negative bacterial strains. Lett. Appl. NanoBioSci., 2013, 2, 97-104.
71. Chifiriuc, M.C.; Grumezescu, A.M.; Andronescu, E.; Ficai, A.; Cotar, A.I.; Grumezescu, V.; Bezirtzoglou, E.; Lazar, V.; Radulescu, R. Water dispersible magnetite nanoparticles influence the efficacy of antibiotics agains planktonic and biofilm embedded Enterococcus faecalis cells. Anaerobe., 2013, 10.1016/j. anaerobe.2013.04.013.
72. Anghel, I.; Grumezescu, A.M.; Andronescu, E.; Anghel, A.G.; Ficai, A.; Saviuc, C.; Grumezescu, V.; Vasile, B.S.; Chifiriuc, M.C. Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development. Nanoscale Res. Lett., 2012, 7, 501.
73. Limban, C.; Grumezescu, A.; Saviuc, C.; Voicu, G.; Chifiriuc, C. Optimized anti-pathogenic agents based on core/shell nanostructures and 2-(4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl)-benzamides. Int. J. Mol. Sci., 2012, 13, 12584-12597.
74. 12 nanostructures and 2-(4-ethylphenoxy) methyl)-N-(substituted-phenylcarbamothioyl)-benzamides. Nanoscale Res. Lett., 2012, 7, 513.
75. Puckett, S.D.; Taylor, E.; Raimondo, T.; Webster, T.J. The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials., 2010, 31, 706-713.
76. 2. J. Biomed. Mater. Res. Part A., 2006, 78A, 595-604.
77. Sousa, C.; Botelho, C.; Oliveira, R. Science against microbial pathogens: communicating current research and technological advances in Nanotechnology applied to medical biofilms control. A. Méndez-Vilas (Ed.), Formatex. (2011) 878-888.
78. Crisante, F.; Francolini, I.; Bellusci, M.; Martinelli, A.; D'Ilario, K.; Piozzi, A. Antibiotic delivery polyurethanes containing alb umin and polyallylamine nanoparticles. Eur. J. Pharm. Sci., 2009, 36, 555-564.
79. Cotar, A.I.; Grumezescu, A.M.; Huang, K.S.; Chifiriuc, C.M.; Radulescu, R. Magnetite nanoparticles influence the efficacy of antibiotics against biofilm embedded Staphylococcus aureus cells. Biointerface Res. Appl. Chem., 2013, 3, 559-565.
80. Rbab, A.S.; Wilson, L.B.; Ashari, P.; Jordan, E.K.; Lewis, B.K.; Frank, J.A. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging, NMR. Biomed., 2005, 18, 383-389.